Mankind Pharma Limited — Call Transcript 2025

Oct 29, 2025

==> picture [559 x 53] intentionally omitted <==

==> picture [559 x 55] intentionally omitted <==

October 29, 2025

BSE Limited

P J Towers, Dalal Street, Mumbai – 400 001

Scrip Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Intimation of Investor Conference Call for Q2 & H1 FY26 with Senior Management of Mankind Pharma Limited (“the Company”)

Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Thursday, November 6, 2025 at 06:00 P.M. (IST) for Q2 & H1 FY26.

Details of the Investor Conference Call are enclosed herewith.

The same are also being uploaded on website of the Company at www.mankindpharma.com.

You are requested to kindly take the same on records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

HITESH Digitally signed by HITESH KUMAR KUMAR JAIN Date: 2025.10.29 JAIN 10:27:54 +05'30' Hitesh Kumar Jain Company Secretary and Compliance Officer

Encl.: A/a

==> picture [557 x 60] intentionally omitted <==

==> picture [148 x 95] intentionally omitted <==

Mankind Pharma Limited Earnings Call Invite | Q2 & H1 FY26

You are cordially invited to the Earnings Call, Scheduled on Thursday, 6[th] November 2025, at 06:00 PM IST, To discuss Q2 & H1 FY26 business performance and results:

The details of the earnings call are as below:

Earnings Call Details	Earnings Call Details
Date	Thursday, 6thNovember 2025
Time	06:00 PM – 07:00 PM IST
Universal Dial-in	+91 22 6280 1102
International Toll-Free Numbers	USA:18667462133UK:08081011573Singapore:8001012045Hong Kong:800964448
Pre-register to avoid wait time	Click here to pre-register for the call and dial in directlywithout waiting for the operator.

Management will be represented by:

• Mr. Rajeev Juneja – Vice Chairman & Managing Director

• Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director

• Mr. Arjun Juneja - Chief Operating Officer

• Mr. Sudipta Roy – Senior President – Sales & Marketing

• Mr. Ashutosh Dhawan – Global Chief Financial Officer

• Mr. Prakash Agarwal – President (Strategy)

• Mr. Abhishek Agarwal – Head - Investor Relations & AVP - Strategy

For details, please contact:

Mankind Pharma LimitedAbhishek AgarwalE:Investor.relations@mankindpharma.com,T: 011 – 46846700	Adfactors PRSnighter Albuquerque / Smit ShahE:Snighter.albuquerque@adfactorspr.com/smit.shah@adfactorspr.com, M: +91 9870789596